Aristotle University Of Thessaloniki (AUTH)
Μελέτη της αγγειογένεσης και της οδού μεταγωγής σήματος του επιδερμικού αυξητικού παράγοντα μετά από χορήγηση του SU011248 σε ασθενείς με προχωρημένο καρκίνωμα κεφαλής και του τραχήλου
Abstract
dc:descriptionThe goal of the present thesis was to study the efficacy and pharmacokinetics of sunitinib and its correlation with the immunohistochemical expression of angiogenic factors and clinical outcome as well as the study of the prognostic role of mRNA expression of angiogenic factors and their receptors in tissues localized laryngeal cancer. In the first part of the study seventeen patients received sunitinib 50 mg daily in six weeks cycles. In the second part 289 patients with localized squamous cell carcinoma of the larynx were retrospectively included in the analysis. Study was stopped prematurely due to inefficiency. None of the investigational biological factors had prognostic role. In localized, operable laryngeal cancer overexpression of VEGFR1 mRNA and VEGFC showed poor correlation with clinical outcome.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Fragkoulidi, Anna
- Φραγκουλίδη, Άννα
Subjects
dc:subject × 14- Υποτροπιάζον καρκίνωμα κεφαλής και τραχήλου
- Σουνιτινίμπη
- Αγγειογένεση
- Ανοσοϊστοχημική έκφραση
- Recurrent head and neck carcinoma
- Sunitinib
- Angiogenesis
- Immunihistochemical expression
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Clinical Medicine
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36943